Bristol-Myers Squibb

(Image: Getty/wutwhanfoto)

FDA greenlights first generics of blood thinner

By Vassia Barba

Mylan and Micro Labs receive US FDA approval for two generic versions of Pfizer and BMS’ Eliquis, marking the first generic approvals of direct oral anticoagulants.

(Image: Getty/Seb_Ra)

BMS-Celgene mega-merger receives shareholder nod

By Ben Hargreaves

The $74bn deal appeared to be fraying around edges, as certain shareholders voiced dissent, but a vote saw the deal pass with support from more than 75% of investors.

(Image: Getty/marchmeena29)

Hired and Retired: Summer Edition

By Ben Hargreaves

in-PharmaTechnologist gives you an overview of some of the notable hires that have taken place in the last month.

People on the Move

People on the Move

People on the Move

By Fiona Barry

Former employees of Procter & Gamble, Merck & Co. and Bristol Myers Squibb have all found new homes in the pharma industry in this week's People column.

AMRI Stock Tumbles After Announcing B-MS Trial Ends

AMRI Stock Tumbles After Announcing B-MS Trial Ends

By Zachary Brennan

Albany Molecular Research's (AMRI) stock fell more than 10% on Monday after announcing in an SEC filing that it was informed by its partner Bristol-Myers Squibb that it would terminate the development of an investigational depression drug.

Pharmaceutical job appointments: people on the move

People on the move: results season special

By Natalie Morrison

Results season is well under way and is here to bring you the latest as companies announce their chops, changes and plans for the coming quarters.


Follow us


Featured Suppliers